miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
about
MicroRNA in rectal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerPredictive Biomarkers to Chemoradiation in Locally Advanced Rectal CancerAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancerOlea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsElevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 yearsIntratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.Identification of serum microRNA profiles in colon cancerFuture directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapymiR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathwayCirculating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.Additional chemotherapy during resting periods after preoperative chemoradiotherapy in patients with rectal cancer.Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc.Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma.miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
P2860
Q26748754-488925A5-8AA5-4BCB-8783-6DB0F09D78F8Q26775610-12A839D8-A205-463A-85EF-EE37F2EFA48EQ26778557-6FFF0F5F-3DF3-4784-B6B3-594D74677EEEQ27024427-6DBBA6B6-D0B9-4052-B95F-F91DF32335F7Q28066481-9BCDE3A9-B814-4C0C-B419-27B69FBF2B0DQ34178530-D3A17C4E-296D-4F67-9BC8-5933EA4EA73EQ34787505-5313794E-4573-4814-BCD4-5F0417640812Q35106877-385F1359-696C-4519-82E1-86AB51C42CABQ35731144-1E69EE59-97C7-446D-BF5E-4DB422425461Q36040119-835864BB-7169-4D10-9C64-4F2A0F7A1A27Q36847230-88BC29E9-E265-41CE-8C12-9B3058FC1A2FQ36889636-ED47BC08-4157-4B8F-9039-6CFE84BC0024Q37106318-14ECC4C3-002E-4C9E-910C-79C366D20B18Q37320821-5985A29C-0059-40C3-86F5-0F0A05DBF584Q37665639-EA933AC3-9C9E-4CA7-B086-E40D4F021B3FQ37709253-40C8B62A-1675-48FA-A251-987167BB0F58Q38432397-DF8A1426-2D9B-4200-9521-7550B71D56D4Q38594617-5B988FC8-656F-4B73-B5C5-2405AEA8EDEAQ38612032-AF73F458-6969-4D87-8A11-5FD2333EAACEQ38623990-F77B62E1-0BE4-458D-A1FA-06923855BFC1Q39246781-B9D6B402-4848-4662-A8ED-90E6047A5F45Q41210209-296D67A5-3DB6-4013-AC81-A209A9B22969Q42087018-45ABB66B-D912-47E7-9E31-BC3B7033F081Q47111822-FEC57298-E787-4463-96C1-CC0F716AE9BDQ47847007-2B0DF5EC-BE85-4B1C-AC31-27963D7102EEQ53515189-412E1684-58E2-47D6-BAB4-078D0BD8B2B3Q55092089-5A3B7EDB-71C0-4C8A-9BA7-EEFE0A538CECQ55508864-673DBDFE-2D88-47C5-926A-908F70DB0721Q58784090-D89DCFC8-C418-434D-B2EC-ED20B9640792
P2860
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@en
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@nl
type
label
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@en
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@nl
prefLabel
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@en
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@nl
P2093
P2860
P1476
miRNA expressions in rectal ca ...... juvant chemoradiation therapy.
@en
P2093
Catherine Curran
Christophe Lemetre
Elrasheid A H Kheirelseid
Emer Hennessey
Graham Balls
Kah Hoong Chang
Margaret Sheehan
Michael J Kerin
Nicola Miller
P2860
P2888
P304
P356
10.1007/S00384-012-1549-9
P50
P577
2012-08-18T00:00:00Z